Patents by Inventor Anne Billotte

Anne Billotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized formulations
    Publication number: 20050170003
    Abstract: The present invention is concerned with means for stabilizing amlodipine maleate to prevent the formation of unwanted Michael adduct and with stabilized pharmaceutical compositions obtained thereby.
    Type: Application
    Filed: March 30, 2005
    Publication date: August 4, 2005
    Inventors: Anne Billotte, Sharon Pavitt, Alan Pettman, Zena Smith
  • Pharmaceutical complex
    Patent number: 6713461
    Abstract: This invention relates to a complex of eletriptan and a sulphobutylether-beta-cyclodextrin, or a pharmaceutically acceptable salt thereof, and to processes for the preparation of, pharmaceutical formulations including, and the uses of, such a complex.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: March 30, 2004
    Assignee: Pfizer Inc.
    Inventor: Anne Billotte
  • Osmotic delivery system
    Publication number: 20030175346
    Abstract: An osmotic pharmaceutical tablet is described which comprises a single-layer compressed core surrounded by a water permeable layer having a passageway. The single-layer core contains (i) a non-ripening drug having a solubility per dose less than about 1 mL−1, (ii) about 2.0% to about 20% by weight of a hydroxyethylcellulose having a weight-average, molecular weight from about 300,000 to about 2,000,000, and (iii) an osmagent.
    Type: Application
    Filed: January 27, 2003
    Publication date: September 18, 2003
    Inventors: Anne Billotte, Rebecca Carrier, Michael B. Fergione, Dwayne T. Friesen, Bruce C. MacDonald, Lee A. Miller, Michael C. Roy, Sheri L. Shamblin, Kenneth C. Waterman
  • Intranasal formulations for treating sexual disorders
    Publication number: 20030158206
    Abstract: Intranasal formulations of sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders.
    Type: Application
    Filed: March 14, 2003
    Publication date: August 21, 2003
    Inventors: Anne Billotte, Peter James Dunn, Brian Thomas Henry, Peter Vallance Marshall, Joanna Jayne Woods
  • Biomodulated multiparticulate formulations
    Publication number: 20030044459
    Abstract: The present invention is concerned with means for adjusting the bioavailability of atorvastatin calcium by modulating its rate of release from multiparticulate formulations and with multiparticulate formulations, especially tablets and capsules, having said modulated rate of release.
    Type: Application
    Filed: August 27, 2002
    Publication date: March 6, 2003
    Applicant: Pfizer Inc.
    Inventor: Anne Billotte
  • Stabilized formulations
    Publication number: 20030027848
    Abstract: The present invention is concerned with means for stabilizing amlodipine maleate to prevent the formation of unwanted Michael adduct and with stabilized pharmaceutical compositions obtained thereby.
    Type: Application
    Filed: June 13, 2002
    Publication date: February 6, 2003
    Inventors: Anne Billotte, Sharon Pavitt, Alan John Pettman, Zena Elizabeth Florence Smith
  • INTRANASAL FORMULATIONS FOR TREATING SEXUAL DISORDERS
    Publication number: 20020040139
    Abstract: Intranasal formulations of sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders.
    Type: Application
    Filed: June 18, 1999
    Publication date: April 4, 2002
    Inventors: ANNE BILLOTTE, PETER JAMES DUNN, BRIAN THOMAS HENRY
  • Pharmaceutical compositions containing eletriptran hemisulphate and caffeine
    Patent number: 6166025
    Abstract: The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg/ml of eletriptan hemisulfate and from 0.5 to 2.0% weight/volume of caffeine.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: December 26, 2000
    Assignee: Pfizer Inc.
    Inventors: Valerie Denise Harding, Anne Billotte